Patents

US 12686853 B2: Methods and compositions for treatment of muscle disease with iPSC-induced human skeletal muscle stem cells

Granted
2026-07-21
Filed
2021-10-25 application 18033756
Type
Utility · 13 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Human skeletal muscle stem cells were generated from facioscapulohumeral muscular dystrophy (FSHD) and healthy control iPSC using a transgene-free skeletal muscle differentiation protocol and production of stable iMyoblasts. Analyses revealed that FSHD and healthy control iMyoblasts are embryonic-like myogenic cells that undergo myotube differentiation ex vivo by growth factor depletion and are efficiently transplantable into the tibialis anterior (TA) muscles of NSG mice, where human muscle under-goes embryonic-to-adult myosin isoform switching. The DUX4 FSHD disease gene maintains its hypomethylated disease state inFSHD iPSC and iMyoblast, and its expression is upregulated during myotube differentiation and in muscle xenografts. Consequently, these iMyoblasts accurately exhibit the molecular pathology of human muscular dystrophies and are useful for the development of drug, gene editing and stem cell therapeutics.

Source: PTBLXML, file of 2026-07-21 (ipgb20260721.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
UNIVERSITY OF MASSACHUSETTS 1,152 patentsUS company or organizationWestborough, MAUNIVERSITY OF MASSACHUSETTS Federal lobbying client EXACT high confidence: identical full name and statePTBLXML, file of 2026-07-21

Inventors

InventorPlacePatentsPerson pageSource
Charles P. EmersonLyndon, VT3PTBLXML, file of 2026-07-21
Dongsheng GuoShrewsbury, MA55PTBLXML, file of 2026-07-21
Katelyn M. DamanStow, MAPTBLXML, file of 2026-07-21
Jing YanShrewsbury, MAPTBLXML, file of 2026-07-21
Jennifer Chee-Jen ChenKingston, CAPTBLXML, file of 2026-07-21
Meng-jiao ShiShrewsbury, MAPTBLXML, file of 2026-07-21
Oliver D. KingSomerville, MA4PTBLXML, file of 2026-07-21
Lawrence J. HaywardSterling, MAPTBLXML, file of 2026-07-21

CPC categories

SubclassCategoryFirst groupSource
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N5/0658PTBLXML, file of 2026-07-21

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2026-01-06Assignment
Assignment of assignor's interest
EMERSON, CHARLES P. signed 2025-11-25
GUO, DONGSHENG signed 2025-11-24
DAMAN, KATELYN M. signed 2025-11-24
YAN, JING signed 2025-11-24
CHEN, JENNIFER CHEE-JEAN signed 2025-11-25
SHI, MENG-JIAO signed 2026-01-06
KING, OLIVER D. signed 2025-11-24
HAYWARD, LAWRENCE J. signed 2025-11-24
UNIVERSITY OF MASSACHUSETTS BOSTON, MA73382/311PASDL, file of 2026-08-13

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.